在小鼠中ADAR1的过度表达不会启动或加速癌症的形成
Shannon Mendez Ruiz1,2, Alistair M Chalk1,2, Ankita Goradia1
1St Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia.
NAR cancer
|June 5, 2023
概括
单独过度表达ADAR1编辑酶的腺氨酸到氨基酸氨基酸并不会引起癌症. 瘤中ADAR1水平的增加可能是癌症发展的后果,而不是原因.
科学领域:
- 分子生物学分子生物学
- 在RNA生物学,RNA生物学.
- 在瘤学瘤学.
背景情况:
- 腺酸转化为 inosine (A-to-I) 的RNA编辑对于细胞过程至关重要.
- 在A-to-I编辑中的关键酶ADAR1在许多人类癌症中被上调.
- 抑制ADAR1是一种潜在的癌症治疗方法,但其致癌作用尚不清楚.
研究的目的:
- 为了调查ADAR1过度表达是否驱动癌症的开始或进展.
- 为了确定ADAR1过度表达是否作为唯一的致癌驱动因素.
- 评估ADAR1在癌症发展中与瘤抑制剂损失合作的潜力.
主要方法:
- 建立了ADAR1及其异形的体内模型,表达过度.
- 在ADAR1过度表达模型中评估癌症的发病和进展.
- 利用一种小鼠骨髓瘤模型来测试ADAR1与瘤抑制剂损失的合作.
主要成果:
- ADAR1或其异型的过度表达作为单个遗传变异并没有导致癌症发病.
- 内生ADAR1和A-to-I编辑在小鼠细胞不朽化时增加.
- 在骨髓瘤模型中,ADAR1过度表达并没有增强或改变疾病.
结论:
- 单单ADAR1的过度表达不足以引起癌症的发生.
- 在癌症中增加ADAR1表达和A-to-I编辑可能是瘤形成的结果,而不是原因.
- 在研究的模型中,ADAR1似乎不是致癌的驱动因素.
相关概念视频
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K


